You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TA-650

Showing 1 - 25 of 520
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Ulcerative Colitis Trial in Japan (TA-650)

Completed
Has Results
  • Pediatric Ulcerative Colitis
  • TA-650
  • Chubu, Japan
  • +6 more
Oct 23, 2019

Von Willebrand Diseases Trial in United States (recombinant von Willebrand factor, tranexamic acid)

Active, not recruiting
  • Von Willebrand Diseases
  • recombinant von Willebrand factor
  • tranexamic acid
  • Gilbert, Arizona
  • +18 more
Jan 26, 2023

Pediatric Crohn's Disease Trial in Japan (TA-650)

Completed
Has Results
  • Pediatric Crohn's Disease
  • TA-650
  • Chubu, Japan
  • +6 more
Jul 11, 2019

Unresectable Pleural Mesothelioma Trial in Worldwide (Volrustomig, Pemetrexed, Carboplatin)

Not yet recruiting
  • Unresectable Pleural Mesothelioma
  • Duarte, California
  • +133 more
Oct 18, 2023

Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin Trial in Japan (TA-650, Polyethylene

Completed
Has Results
  • Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
  • TA-650
  • Polyethylene Glycol-treated Human Immunoglobulin (VGIH)
  • Chubu, Japan
  • +7 more
Sep 28, 2018

Head Neck Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Cetuximab)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Anaheim, California
  • +72 more
Jul 28, 2022

Early Diagnosis of Transplant-associated Thrombotic

Not yet recruiting
  • Thrombotic Microangiopathies
  • Hematopoietic Stem Cell Transplantation
    • (no location specified)
    Oct 22, 2023

    Non Small Cell Lung Carcinoma NSCLC Trial in Worldwide (Durvalumab +Tremelimumab, Paclitaxel + carboplatin, Gemcitabine +

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Carcinoma NSCLC
    • Durvalumab +Tremelimumab
    • +5 more
    • Anaheim, California
    • +210 more
    Jan 4, 2023

    Parathyroid Adenoma Trial (18Fluorocholine)

    Not yet recruiting
    • Parathyroid Adenoma
    • (no location specified)
    May 26, 2023

    Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

    Not yet recruiting
    • Bladder Cancer
    • Scottsdale, Arizona
    • +241 more
    Feb 9, 2023

    Healthy Trial in Seoul (Acetaminophen)

    Completed
    • Healthy
    • Seoul, Korea, Republic of
      H plus Yangji Hospital
    Jan 3, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    Advanced Solid Tumors Trial in Worldwide (AMG 650)

    Active, not recruiting
    • Advanced Solid Tumors
    • AMG 650
    • Los Angeles, California
    • +21 more
    Jan 26, 2023

    Cancer Trial in New York (Therapeutic Alliance)

    Not yet recruiting
    • Cancer
    • Therapeutic Alliance
    • Duarte, California
      City of Hope Medical Center
    Dec 20, 2022

    Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

    Withdrawn
    • Recurrent Human Papillomavirus Type 16 Associated Cancer
    • HPV 16 TA-CIN
    • Birmingham, Alabama
    • +1 more
    Nov 29, 2022

    NSCLC, ALK Gene Rearrangement Positive Trial in United States (Ensartinib)

    Available
    • Non-Small Cell Lung Cancer
    • ALK Gene Rearrangement Positive
    • Stanford, California
    • +3 more
    Oct 18, 2022

    Episiotomy Wound, Anemia, Early Postpartum Hemorrhage Trial (Tranexamic acid, Placebo)

    Recruiting
    • Episiotomy Wound
    • +3 more
    • Tranexamic acid
    • Placebo
    • Ashdod, Shfela, Israel
      Assuta ashdod
    Aug 31, 2022

    Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

    Recruiting
    • Metastatic Prostate Cancer
    • Prostate Adenocarcinoma
    • Tucson, Arizona
    • +259 more
    Oct 19, 2022

    Critical Illness Trial in Mansoura (Lactoferrin)

    Not yet recruiting
    • Critical Illness
    • Mansoura, El-dakhlia, Egypt
      Mansoura University hospital
    Jul 6, 2023

    The Early Life Clinical Feature and Risk Factors Analysis in

    Recruiting
    • Premature Infant
      • Taoyuan, Taiwan
        Chang Gung Memorial Hospital
      Jun 22, 2022

      Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)

      Recruiting
      • Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
      • Tacrolimus ointment
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Jan 15, 2023

      Pompe Disease Trial in Gainesville (genetic, drug, other)

      Completed
      • Pompe Disease
      • Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
      • +7 more
      • Gainesville, Florida
        Clinical and Translational Research Building (CTRB), University
      Mar 24, 2022

      Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (MEDI4736, Tremelimumab, MEDI4736+Tremelimumab)

      Completed
      Has Results
      • Squamous Cell Carcinoma of the Head and Neck
      • MEDI4736
      • +6 more
      • Aurora, Colorado
      • +196 more
      Sep 16, 2021

      Telomere Shortening, Aging, Vascular Diseases Trial (TA-65, Placebo)

      Not yet recruiting
      • Telomere Shortening
      • +2 more
      • TA-65
      • Placebo
      • (no location specified)
      Oct 24, 2022

      APS Secondary to SLE

      Recruiting
      • Antiphospholipid Syndrome
      • Jinan, Shandong, China
        Qilu Hospital
      Nov 30, 2022